Evidence map›Paper›PMID 26554386›Full record

ArticlePsychopharmacology2016

Differential modulation of methamphetamine-mediated behavioral sensitization by overexpression of Mu opioid receptors in nucleus accumbens and ventral tegmental area.

Chi-Chung Kuo, Hui Shen, Brandon K Harvey, Seong-Jin Yu, Theresa Kopajtic, Josh J Hinkle, Stephanos Kyrkanides, Jonathan L Katz, Yun Wang

Open access · greenAbstract read
In one paragraph

Article in Psychopharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Chi-Chung KuoIntramural Research Program, National Institute on Drug Abuse, NIH, Baltimore, MD, 21224, USA.
Hui ShenIntramural Research Program, National Institute on Drug Abuse, NIH, Baltimore, MD, 21224, USA.
Brandon K HarveyIntramural Research Program, National Institute on Drug Abuse, NIH, Baltimore, MD, 21224, USA.
Seong-Jin YuCenter for Neuropsychiatric Research, National Health Research Institutes, Miaoli, Taiwan.
Theresa KopajticCenter for Neuropsychiatric Research, National Health Research Institutes, Miaoli, Taiwan.
Josh J HinkleIntramural Research Program, National Institute on Drug Abuse, NIH, Baltimore, MD, 21224, USA.
Stephanos KyrkanidesDepartment of Children's Dentistry, Stony Brook University Health Science Center, Stony Brook, NY, 11794-8701, USA.
Jonathan L KatzIntramural Research Program, National Institute on Drug Abuse, NIH, Baltimore, MD, 21224, USA.
Yun WangCenter for Neuropsychiatric Research, National Health Research Institutes, Miaoli, Taiwan. ywang@intra.nida.nih.gov.
National Institute on Drug Abuse · USNational Health Research Institutes · TWStony Brook University · US

Funding

Optogenetics and Transgenic Technology CoreZICDA000555 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI HARVEY, BRANDON · 2009 to 2017
$10.0M
Microglia, HIV and drugs of abuseZIADA000586 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI HARVEY, BRANDON · 2012 to 2025
$6.6M
Basic Dopamine Transporter Mechanisms Of CocaineZIADA000103 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI KATZ, JONATHAN L · 2009 to 2016
$4.6M
Gene Delivery and AddictionZIADA000526 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI HARVEY, BRANDON · 2009 to 2022
$3.2M
Gene Delivery and AddictionZ01DA000526 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI HARVEY, BRANDON · 2008 to 2008
$498k
Intramural NIH HHS Z01 DA000526
6 · The paper itself

Abstract

rationaleRepeated administration of methamphetamine (Meth) induces behavioral sensitization which is characterized by a progressive increase in locomotor response after each injection. Previous studies have shown that Mu opioid receptors (MORs) can regulate Meth-mediated behavioral sensitization. However, the reported interactions are controversial; systemic activation of MORs either enhanced or suppressed Meth sensitization. It is possible that alteration of Meth sensitization after systemic administration of MOR ligands reflects the sum of distinct MOR reactions in multiple brain regions.

objectivesThe purpose of the present study was to examine the actions of MORs on Meth sensitization after regionally selective overexpression of human MOR through an AAV6-based gene delivery system.

methodWe demonstrated that adeno-associated virus (AAV)-MOR increased MOR immunoreactivity and binding in vitro. AAV-MOR or AAV-green fluorescent protein (GFP) was injected into the nucleus accumbens (NAc) or ventral tegmental area (VTA) of adult mice. Two weeks after viral infection, animals received Meth or saline for five consecutive days. Locomotor behavior and striatal dopamine (DA) and 3,4-dihydroxyphenylacetic acid (DOPAC) level were determined.

resultsRepeated administration of Meth progressively increased locomotor activity; this sensitization reaction was attenuated by intra-NAc AAV-MOR microinjections. Infusion of AAV-MOR to VTA enhanced Meth sensitization. AAV-MOR significantly enhanced DA levels in VTA after VTA infection but reduced DOPAC/DA turnover in the NAc after NAc injection.

conclusionOur data suggest a differential modulation of Meth sensitization by overexpression of MOR in NAc and VTA. Regional manipulation of MOR expression through AAV may be a novel approach to control Meth abuse and psychomimetic activity.

Indexed as

3,4-Dihydroxyphenylacetic AcidAnimalsDopamineDose-Response Relationship, DrugEnkephalin, Ala(2)-MePhe(4)-Gly(5)-Gene Expression RegulationHumansMaleMethamphetamineMiceMice, Inbred C57BLMicroinjectionsMotor ActivityNucleus AccumbensReceptors, Opioid, muVentral Tegmental Area3,4-Dihydroxyphenylacetic AcidDopamineEnkephalin, Ala(2)-MePhe(4)-Gly(5)-MethamphetamineReceptors, Opioid, muAAVMethamphetamineMu opioid receptorSensitization

Identifiers

PMID26554386
PMCPMC7336502
OpenAlexW2133324609

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.